20
Participants
Start Date
November 17, 2017
Primary Completion Date
December 20, 2018
Study Completion Date
February 25, 2019
LaseMD and DUAL 1927nm Laser
Laser treatment of benign pigmented lesion based on photothermolysis whereby the target molecule, the chromophore, absorbs a delivered wavelength of light over a period of time to damage the target while limiting collateral damage to adjacent structures, leading to pigmentary clearance.
LaseMD
Laser treatment of benign pigmented lesion using optimized treatment settings.
Maryland Dermatology Laser, Skin & Vein Institute, Hunt Valley
Dermatology, Laser, and Vein Specialists of the Carolinas, Charlotte
Lead Sponsor
LUTRONIC Corporation
INDUSTRY